1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane has been researched along with propofol in 1 studies
| Studies (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Trials (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Recent Studies (post-2010) (1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane) | Studies (propofol) | Trials (propofol) | Recent Studies (post-2010) (propofol) |
|---|---|---|---|---|---|
| 40 | 0 | 5 | 16,827 | 5,188 | 6,805 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchholz, BA; Carpenter, TS; Casida, JE; Hammock, BD; Hwang, SH; Lightstone, F; Lightstone, FC; Yang, J; Zhao, C | 1 |
1 other study(ies) available for 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane and propofol
| Article | Year |
|---|---|
GABAA receptor target of tetramethylenedisulfotetramine.
Topics: Amides; Animals; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Carbon Isotopes; Carbon Radioisotopes; Formaldehyde; GABA Agonists; GABA-A Receptor Antagonists; Heterocyclic Compounds; Humans; Hypnotics and Sedatives; Insecticides; Isonicotinic Acids; Models, Molecular; Molecular Conformation; Molecular Structure; Propofol; Pyridoxine; Radioligand Assay; Rats; Receptors, GABA-A; Sulfur; Vitamin B Complex | 2014 |